Dec 3, 2021 | Car Problems Car Complaints
Honda Passport (2019), Honda Pilot (2016-2019), Honda Ridgeline (2017-2020)
Your vehicle MAY be involved in a safety recall which MAY create a safety risk for you or your passengers. If left unrepaired, a potential safety defect could lead to injury or even death. Safety defects must be repaired by a dealer at no cost to you. The following MAY APPLY to your vehicle if it is listed below. Please click on the National Highway Traffic Safety Administration (“NHTSA”) Recall ID Number below to learn more about the safety issue and the reason for the vehicle recall.
Manufacturer: Honda (American Honda Motor Co.)
Components: STRUCTURE, LATCHES/LOCKS/LINKAGES
Potential Number of Units Affected: 724,826
Summary & Remedy
Honda (American Honda Motor Co.) is recalling certain 2019 Passport, 2016-2019 Pilot, and 2017-2020 Ridgeline vehicles. The hood latch striker may become damaged and separate from the hood, which can result in the hood opening while driving.
Dealers will either repair the hood latch striker, or replace the hood if necessary, free of charge. Owner notification letters are expected to be mailed January 17, 2022. Owners may contact Honda customer service at 1-888-234-2138. Honda’s number for this recall is PBV. Owners may also contact the National Highway Traffic Safety Administration Vehicle Safety Hotline at 1-888-327-4236 (TTY 1-800-424-9153), or go to nhtsa.gov.
What Is A Vehicle Recall?
When a manufacturer or the NHTSA determines that a vehicle creates an unreasonable risk to safety or fails to meet minimum safety standards, the manufacturer is required to fix that vehicle at no cost to the owner. The fix, or repair, can be accomplished by repairing, replacing, offering a refund (for equipment) or, in rare cases, repurchasing the car/vehicle.
What should I do if my vehicle is included in this recall?
If your vehicle is included in a specific recall, it is very important that you get it fixed as soon as possible given the potential danger to you and your passengers if it is not addressed. You should receive a separate letter in the mail from the vehicle manufacturer, notifying you of the recall and explaining when the remedy will be available, whom to contact to repair your vehicle, and to remind you that the repair will be done at no charge to you. If you believe your vehicle is included in the recall, but you do not receive a letter in the mail from the vehicle manufacturer, please call NHTSA’s Vehicle Safety Hotline at 1-888-327-4236, or contact your vehicle manufacturer or dealership.
For additional recall information, please click Vehicle Recall FAQs.
Source: U.S. Department of Transportation, National Highway Traffic Safety Administration
VEHICLE OWNERS AND LESSEES AFFECTED BY AUTOMOTIVE DEFECTS OR SAFETY RECALLS ARE ENCOURAGED TO CONTACT KEHOE LAW FIRM, P.C., [email protected], FOR A FREE, NO-OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.
Dec 3, 2021 | Shareholder Investigations
ReneSola Investors Who Have Suffered Financial Losses Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether ReneSola Ltd. (“ReneSola” or the “Company”) (NYSE: SOL) violated federal securities laws or engaged in other unlawful business practices.
On December 2, 2021, SeekingAlpha reported that “ReneSola . . . dropped 17% after a new short report from Grizzy Research, which sees 40% downside for the shares.” SeekingAlpha reported that ReneSola Ltd., according to Grizzly Research, “. . . is ‘drastically’ overrepresenting its project pipeline and it claims that legal difficulties with SOL’s biggest shareholder will cause ‘significant issues’ for shareholders.”
RENESOLA INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES AND SUFFERED FINANCIAL LOSSES ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE
INVESTORS ARE ALSO ENCOURAGED TO CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Dec 2, 2021 | Shareholder Investigations
WeWork To Restate Financials – Company Discloses Material Weakness In Internal Control Over Financial Reporting Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether WeWork, Inc. (“WeWork” or the “Company”) (NYSE: WE) violated federal securities laws or engaged in other unlawful business practices.
In a December 1, 2021 Form 8-K, WeWork disclosed that it “. . . plans to restate . . . financial statements as of December 31, 2020 in an amendment to the 2020 Form 10-K/A and the unaudited interim financial statements as of March 31, 2021, June 30, 2021, and September 30, 2021 in an amendment to the Q3 Form 10-Q, both to be filed with the SEC.”
The Company also stated that its “. . . management has concluded that . . . there was a material weakness in internal control over financial reporting relating to the interpretation and accounting for certain complex features of the Public Shares.”
On this news, WeWork’s stock dropped, thereby injuring investors.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES AND SUFFERED FINANCIAL LOSSES ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE
WEWORK INVESTORS ARE ALSO ENCOURAGED TO CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Dec 1, 2021 | Data Breach
Data Breach Of DNA Diagnostics Center’s Network Resulting In Unauthorized Access And Acquisition Of Archived Database With Personal Information
In a press release (“DNA Diagnostics Center, Inc. Provides Notice of Data Security Incident”) on the website of the State of California Department of Justice, Office of the Attorney General, DNA Diagnostics Center, Inc. advised that “[o]n August 6, 2021, DNA Diagnostics Center, Inc. (DDC) detected potential unauthorized access to its network, during which there was unauthorized access and acquisition of an archived database that contained personal information collected between 2004 and 2012. The impacted database was associated with a national genetic testing organization system that DDC acquired in 2012. This system has never been used in DDC’s operations and has not been active since 2012.”
DDC’s press release also stated that “[t]he impacted database was associated with a national genetic testing organization that DDC has never used in its operations and has not been active since 2012. DDC acquired certain assets from this national genetic testing organization in 2012 that included certain personal information, and therefore, impacts from this incident are not associated with DDC.” Further, the press release stated that “[i]mpacted individuals may have had their information, such as Social Security numbers or payment information, impacted as a result.” [Emphasis added.]
Additional information about the data breach can be found by clicking “Data Security Incident Information Center,” a document also located on the California Attorney General’s website related to the data incident.
Informationsecuritybuzz.com reported that “DNA Diagnostics Center . . ., a US-based DNA testing company, has disclosed a hacking incident that affects 2,102,436 persons. The incident resulted in a confirmed data breach that occurred between May 24, 2021, and July 28, 2021, but the firm discovered it only on October 29, 2021.” According to informationsecuritybuzz.com, the breached information includes full names, credit and debit card number (plus CVV), financial account number and and platform account password.
Have You Been Impacted by A Data Breach?
If so, please complete the form on the right or contact Kehoe Law Firm, P.C., [email protected], for a free, no-obligation evaluation of potential legal claims.
Examples of the type of relief sought by data privacy class actions, include, but are not limited to, reimbursement of identity theft losses and of out-of-pocket costs paid by data breach victims for protective measures such as credit monitoring services, credit reports, and credit freezes; compensation for time spent responding to the breach; imposition of credit monitoring services and identity theft insurance, paid for by the defendant company; and improvements to the defendant company’s data security systems.
Data privacy class actions are brought on a contingent-fee basis; thus, plaintiffs and the class members do not pay out-of-pocket attorney’s fees or litigation costs. Subject to court approval, attorney’s fees and litigation costs are derived from the recovery obtained for the class.
Nov 30, 2021 | Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ: FENC) violated federal securities laws or engaged in other unlawful business practices.
FENNEC INVESTORS WITH FINANCIAL LOSSES GREATER THAN $25,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE.
On November 29, 2021, Fennec reported that “. . . it expects the U.S. Food and Drug Administration will not accept the company’s New Drug Application for PEDMARK™.”
The Company also stated that “. . . it expects to receive a Complete Response Letter (CRL) after the PDUFA target action date of November 27, 2021 from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for PEDMARKTM (a unique formulation of sodium thiosulfate), for intravenous administration for the prevention of ototoxicity associated with cisplatin chemotherapy in pediatric patients ≥1 month to 18 years of age with localized, non-metastatic, solid tumors.”
Further, Fennec reported that “[t]he FDA has indicated that, following a recent completion of a pre-approval inspection of the manufacturing facility of our drug product manufacturer, deficiencies have been identified.”
On this news, shares of Fennec declined $4.86 per share on November 29, 2021, thereby injuring investors. During intraday trading on November 30, 2021, Fennec shares were down more than 6%.
FENNEC INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES AND LOST MORE THAN $25,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE FENNEC SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
